http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11097004-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_039dbe220404f382590149772c395a45
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55588
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
filingDate 2019-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6d82531fd79cef06198babe8201a926
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a51123d43bb01ddace42da93857ff511
publicationDate 2021-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-11097004-B2
titleOfInvention Composition for immunotherapy and preparation method thereof
abstract The present invention provides a serum and its blood components isolated from blood, wherein the blood is drawn from body of a patient, and a normal saline solution mixed with the serum and its blood components, characterized in that a Reagent A having at least one type of adjuvant, and a Reagent B having at least one type of transfer factor peptide and a buffered saline, and Reagent C having an alpha lipoic acid are added to the mixture of the serum and its blood components and the normal saline solution, such that the composition enhances cell-mediated immunity and T suppressor cells in the patient to act against autoimmune disease. The present invention also provides a method for producing such composition for immunotherapy thereof.
priorityDate 2019-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004001847-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004234513-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018138682-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92034525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582418
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449504222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21651365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804

Total number of triples: 40.